Progression of calcifications in breast arteries in women at high risk for coronary heart disease events

Netherlands Heart Journal

Volumn 14, Issue 9, 2006, Pages 287-291

  Maas, A H E M ^a   Van Der Schouw, Y T ^b   Mali, W P Th M ^b   Van Der Graaf, Y ^b  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; Calcification; Mammogram; Progression; Risk factor

Indexed keywords

ANTILIPEMIC AGENT; RALOXIFENE;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; BREAST CALCIFICATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; SCORING SYSTEM;

EID: 33750888573     PISSN: 09297456     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender and age. Results from the multi-ethnic study of atherosclerosis (MESA). Circulation 2006;113:30-7.
2. Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:331-6.
3. Sutton-Tyrrell K, Kuller LH, Edmundowicz D, Feldman A, Holubkov R, Givens L, et al. Usefulness of electron beam tomography to detect progression of coronary and aortic calcium in middle-aged women. Am J Cardiol 2001;87:560-4.
4. O'Donnell CJ, Chazaro I, Wilson PWF, Fox C, Hannan MT, Kiel DP, Cupples LA. Evidence for heritability of abdominal aortic calcine deposits in the Framingham Heart Study. Circulation 2002;106:337-41.
5. Hsia J, Klouj A, Prasad A, Burt J, Adams-Campbell LL, Howard BV. Progression of coronary calcification in healthy postmenopausal women. BMC Cardiovasc Disord 2004;4:21-6.
6. Lehto S, Niskanen L, Suhonen M, et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Throm Vasc Biol 1996;16:978-83.
7. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001;60:472-9.
8. Maas AH, van der Schouw YT, Mali WP, van der Graaf Y. Prevalence and determinants of breast arterial calcium in women at high risk of cardiovascular disease. Am J Cardiol 2004;94::655-9.
9. Kemmeren JM, Beijerinck D, van Noord PA, Banga JD, Deurenberg JJ, Pameijer FA, et al. Breast arterial calcifications: associations with diabetes mellitus and cardiovascular mortality. Radiology 1996;201:75-8.
10. Maas AH, van der Schouw YT, Atsma F, Beijerinck D, Deurenberg JJ, Mali WP, et al. Breast arterial calcifications are correlated with subsequent development of coronary artery calcifications but their aetiology is predominantly different [submitted].
11. Mosca L, Barrett-Connor E, Wenger NK, Collins P, Grady D, Kornitzer M, et al. Design and methods of the Raloxifene Use for The Heart (RUTH) study. Am J Cardiol 2001;88:392-5.
12. Wenger NK, Barrett-Connor E, Collins P, Grady D, Kornitzer M, Mosca L, et al. Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) Trial. Am J Cardiol 2002;90:1204-10.
13. Barrett-Connor E, Laughlin GA. Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study. Menopause 2005;12:40-8.
14. Schisterman EF, Gallagher AM, Bairey Merz CN, Whitcomb BW, Faraggi D, Moysich KB, et al. The association of hormone replacement therapy and coronary calcium as determined by electron beam tomography. J Women's Health 2002;11:631-8.
15. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women. J Clin Endocrinol Metab 2002;87:1062-7.
16. Mackey RH, Kuller LH, Sutton-Tyrrell K, Evans RW, Holubkov R, Matthews KA. Hormone therapy, lipoprotein subclasses, and coronary calcification. Arch Intern Med 2005;165:510-5.
17. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl Med 2005;353:1773-83.
18. Yoon HC, Emerick AM, Hill JA, Gjertson DW, Goldin JG. Calcium begets calcium: progression in asymptomatic subjects. Radiology 2002;224:236-41.
19. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary disease as assessed by electron-beam computed tomography. N Engl J Med 1998;339:1972-8.
20. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women. Beyond endorsed lipid lowering with EBT scanning (BELLES). Circulation 2005;112:563-71.
21. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C and vitamin E. The St. Francis Heart study randomized clinical trial. J Am Coll Cardiol 2005;46:166-72.
22. Schmermund A, Aschenbach S, Budde T, Buziashvili Y, Förster A, Friedrich G, et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified atherosclerosis over 12 months. Circulation 2006;113:427-37.
23. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge JB, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97.
24. Mundy G, Garret R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-9.
25. Wu B, Elmariah S, Kaplan FS, Cheng G, Mohler III ER. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts. Implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol 2005;25:592-7.
26. Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol 2004;24:1272-7.
27. Crystal P, Crystal E, Leor J, Friger M, Katzinovitch G, Strano S. Breast artery calcium on routine mammography as a potential marker for increased risk of cardiovascular disease. Am J Cardiol 2000;86:216-7.
28. Iribarren C, Go AS, Tolstykh I, Sidney S, Johnston SC, Spring DB. Breast vascular calcification and risk of coronary heart disease, stroke, and heart failure. J Women's Health 2004;13:381-9.
29. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 2004;286:E686-E696.
30. Abedin M, Tintut Y, Demer LL. Vascular calcification. Mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004;24:1161-70.
31. Doherty TM, Fitzpatrick LA, Inoue D, Qiao JH, Fishbein MC, Detrano RC, et al. Molecular, endocrine and genetic mechanisms of arterial calcification. Endocrine Reviews 2004;25:629-72.
32. Peyser PA, Bielak LF, Chu JS, Turner ST, Ellsworth DL, Boerwinkle E, Sheedy II PF. Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults. Circulation 2002;106:304-8.
33. Ortlepp JR, Schmitz F, Mevissen V, Weis S, Huster J, Dronskowski R, et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J 2004;25:514-22.